EDESA BIOTECH, INC. Amortization of Intangible Assets
EDESA BIOTECH, INC. (EDSA) reported Amortization of Intangible Assets of $30.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-13
- EDESA BIOTECH, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $30.00K, a 0.00% change year-over-year.
- EDESA BIOTECH, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $30.00K, a 0.00% change year-over-year.
- EDESA BIOTECH, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $30.00K, a 0.00% change year-over-year.
- EDESA BIOTECH, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $101.17B, a 0.00% change year-over-year.
- EDESA BIOTECH, INC. amortization of intangible assets for fiscal 2025 was $101.17B, a 0.00% change from fiscal 2024.
- EDESA BIOTECH, INC. amortization of intangible assets for fiscal 2024 was $101.17B, a 0.00% change from fiscal 2023.
- EDESA BIOTECH, INC. amortization of intangible assets for fiscal 2023 was $101.17B, a 9900.00% increase from fiscal 2022.
- EDESA BIOTECH, INC. amortization of intangible assets for fiscal 2022 was $1.01B.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30.00K 10-Q · filed 2026-08-13 | $60.00K derived: sum of 2 quarters · filed 2026-08-13 | $80.00K 10-Q · filed 2026-08-13 | $101.17B derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $30.00K 10-Q · filed 2026-05-14 | $50.00K 10-Q · filed 2026-05-14 | $101.17B derived: sum of 3 quarters · filed 2026-05-14 | $101.17B derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $30.00K 10-Q · filed 2026-02-13 | $101.17B derived: sum of 2 quarters · filed 2026-02-13 | $101.17B derived: sum of 3 quarters · filed 2026-08-13 | $101.17B derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-09-30 | $101.17B derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | $101.17B derived: sum of 2 quarters · filed 2026-08-13 | $101.17B derived: sum of 3 quarters · filed 2026-08-13 | $101.17B 10-K · filed 2025-12-12 | ||
| 2025-06-30 | $30.00K 10-Q · filed 2026-08-13 | $60.00K derived: sum of 2 quarters · filed 2026-08-13 | $80.00K 10-Q · filed 2026-08-13 | $101.17B derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $30.00K 10-Q · filed 2026-05-14 | $50.00K 10-Q · filed 2026-05-14 | $101.17B derived: sum of 3 quarters · filed 2026-05-14 | $101.17B derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $30.00K 10-Q · filed 2026-02-13 | $101.17B derived: sum of 2 quarters · filed 2026-02-13 | $101.17B derived: sum of 3 quarters · filed 2026-02-13 | $101.17B derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2024-09-30 | $101.17B derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | $101.17B derived: sum of 2 quarters · filed 2025-12-12 | $101.17B derived: sum of 3 quarters · filed 2025-12-12 | $101.17B 10-K · filed 2025-12-12 | ||
| 2024-06-30 | $30.00K 10-Q · filed 2025-08-08 | $60.00K derived: sum of 2 quarters · filed 2025-08-08 | $80.00K 10-Q · filed 2025-08-08 | $101.17B derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2024-03-31 | $30.00K 10-Q · filed 2025-05-14 | $50.00K 10-Q · filed 2025-05-14 | $30.00K 10-Q · filed 2024-05-10 | $101.17B derived: sum of 3 quarters · filed 2025-05-14 | $101.17B derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $30.00K 10-Q · filed 2025-02-14 | $101.17B derived: sum of 2 quarters · filed 2025-02-14 | $101.17B derived: sum of 3 quarters · filed 2025-02-14 | $101.17B derived: sum of 4 quarters · filed 2025-02-14 | ||
| 2023-09-30 | $101.17B derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-13 | $101.17B derived: sum of 2 quarters · filed 2024-12-13 | $101.17B derived: sum of 3 quarters · filed 2024-12-13 | $101.17B 10-K · filed 2024-12-13 | $1.01B 10-K · filed 2023-12-15 | |
| 2023-06-30 | $30.00K 10-Q · filed 2024-08-09 | $60.00K derived: sum of 2 quarters · filed 2024-08-09 | $80.00K 10-Q · filed 2024-08-09 | $1.01B derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $30.00K 10-Q · filed 2023-05-11 | $50.00K 10-Q · filed 2024-05-10 | $1.01B derived: sum of 3 quarters · filed 2024-02-09 | $1.01B derived: sum of 4 quarters · filed 2024-02-09 | ||
| 2022-12-31 | $30.00K 10-Q · filed 2024-02-09 | $1.01B derived: sum of 2 quarters · filed 2024-02-09 | $1.01B derived: sum of 3 quarters · filed 2024-02-09 | $1.01B derived: sum of 4 quarters · filed 2024-02-09 | ||
| 2022-09-30 | $1.01B derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | $1.01B derived: sum of 2 quarters · filed 2023-12-15 | $1.01B derived: sum of 3 quarters · filed 2023-12-15 | $1.01B 10-K · filed 2023-12-15 | ||
| 2022-06-30 | $30.00K 10-Q · filed 2023-08-09 | $60.00K derived: sum of 2 quarters · filed 2023-08-09 | $80.00K 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | $30.00K 10-Q · filed 2023-05-11 | $50.00K 10-Q · filed 2023-05-11 | ||||
| 2020-09-30 | $45.95K 10-K · filed 2020-12-07 | |||||
| 2019-09-30 | $0.00 10-K · filed 2020-12-07 | |||||
| 2014-08-31 | $26.19K 10-K · filed 2016-12-14 | |||||
| 2014-06-30 | $7.14K 10-Q · filed 2015-08-10 | $21.43K 10-Q · filed 2015-08-10 | ||||
| 2013-08-31 | $28.57K 10-K · filed 2015-12-14 | |||||
| 2012-08-31 | $28.57K 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |